Paxillin: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 25: | Line 25: | ||
**[[4xgz]], [[4xh2]] – hPXN + antibody<br /> | **[[4xgz]], [[4xh2]] – hPXN + antibody<br /> | ||
**[[1ow8]], [[1ow7]] – hPXN + focal adhesion kinase focal adhesion targeting domain <br /> | **[[1ow8]], [[1ow7]] – hPXN + focal adhesion kinase focal adhesion targeting domain <br /> | ||
**[[5w93]] – | **[[5w93]] – mPXN + P130CAS - mouse<br /> | ||
*Paxillin LD4 (residues 20-41) | *Paxillin LD4 (residues 20-41) | ||
| Line 41: | Line 41: | ||
**[[5uwh]] – hPXN + RAN + CRM1 + RANBP1<br /> | **[[5uwh]] – hPXN + RAN + CRM1 + RANBP1<br /> | ||
**[[3u3f]] – hPXN + tyrosine kinase PYK2 focal adhesion domain<br /> | **[[3u3f]] – hPXN + tyrosine kinase PYK2 focal adhesion domain<br /> | ||
**[[6jmu]] – mPXN + GIT1<br /> | |||
*Paxillin proline-rich region (residues 45-54) | *Paxillin proline-rich region (residues 45-54) | ||
